Cereno is planning to launch a new Phase 1 clinical trial to evaluate the pharmacological properties of CS014 in healthy ...

Living with PH feels like an endless financial balancing act, leaving columnist Jen Cueva constantly on the verge of going broke.

Researchers developed prediction models to identify premature infants with bronchopulmonary dysplasia who are at risk of ...

Scientists have uncovered key genetic drivers behind blood vessel damage in idiopathic PAH, according to a study.

Requiring continuous flow oxygen is a physical and mental burden, writes columnist Anna Jeter, whose needs have increased over time.

I recently went to Washington, D.C., as part of the Pulmonary Hypertension Association’s (PHA) Capitol Hill Day to advocate for the pulmonary hypertension (PH) community and help secure co-sponsorship ...